- Report
- September 2024
- 13 Pages
China
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
Germany
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
Asia Pacific
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
United States
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
India
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
North America
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
Japan
From €907EUR$950USD£760GBP
- Report
- September 2024
- 13 Pages
Latin America
From €907EUR$950USD£760GBP
- Book
- September 2023
Global
- Book
- August 2014
Global
Adenosine is a drug used in the treatment of endocrine and metabolic disorders. It is a purine nucleoside that acts as a neuromodulator, regulating the activity of various neurotransmitters and hormones. Adenosine is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to treat certain types of heart failure, as well as to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms.
Adenosine is a widely used drug in the endocrine and metabolic disorders market. It is used to treat a variety of conditions, including diabetes, obesity, and hypoglycemia. It is also used to reduce the risk of stroke and other cardiovascular diseases. Adenosine is available in both oral and injectable forms, and is often prescribed in combination with other drugs.
Some companies in the Adenosine market include Novartis, Merck, Pfizer, Sanofi, and GlaxoSmithKline. Show Less Read more